Tyra Bio - Wutah bathi EPS kuartalan TYRA

Logo korporat perusahaan Tyra Biosciences (TYRA)

Tyra Biosciences, Inc. (TYRA) is currently burning capital on costly research without current sales. Quarterly net income per share dynamics demonstrate a market imbalance, where the -47.90 metric serves as the target level. Prospects rely on the success of the TYRA-300 drug and fund support, however, geopolitical strife and sanctions seriously hinder international biomaterial logistics and the execution of global trials.

Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan tyra.bio (TYRA): kanggo periode 04.07.2022 - 17.11.2026

Rincian analitis perusahaan Tyra Biosciences, Inc.

- rega saham lan konsensus proyeksi valuasi:
Pambiji fundamental perusahaan:tyra.bio - TYRA
Barang unggulan tyra.bio

Quarterly EPS growth measures the dynamics of net income per share, filtering out market noise to assess real profitability. Investors analyze this metric to verify the sustainability of the business's cash flows. By studying the growth rates of quarterly net income per share, one can detect liquidity shortages in advance. For Tyra Biosciences, Inc. (TYRA), this metric reflects the efficiency of investments in precision oncology. Innovative molecular design must convert into stable financial strengthening for the company.

Analisis perusahaan pesaing

GMAB (Genmab) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|EXEL: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|NUVL (Nuvalent Therapeutics) - Wutah bathi EPS kuartalan|Wutah bathi EPS kuartalan kymeratx.com|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan IDEAYA Biosciences, Inc. (IDYA)|ELVN (Enliven Therapeutics, Inc.) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan ORIC (ORIC Pharmaceuticals Inc)|Wutah bathi resik saben saham sajroning taun lumaku Relay Pharma|Nurix Therapeutics Inc - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Verastem|GLUE (Monte Rosa Therapeutics) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|CGEM: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|IMRX (immuneering.com) - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan C4 Tx CCCC|Wutah bathi EPS kuartalan BDTX|Repare Therapeutics Inc. - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|PMV Pharmaceuticals, Inc. - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan KPTI|PPCB: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Cyclacel Pharmaceuticals - Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|AADI: Wutah bathi EPS kuartalan|Aileron Therapeutics Inc - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|BPMC (Blueprint Medicines Corp.) - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan glycomimetics.com GLYC|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan SpringWorks (SWTX)